Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 1997

View Archived Issues

Annual Report: Triangle Pharmaceuticals

TK signal transduction modulators claimed by Sugen

BASF focuses on dolastatin derivatives

Novel anti-HIV compounds disclosed by Novartis

Chiron prepares uPA inhibitors

Human Genome Sciences discloses novel human polypeptide for cancer

Apoptosis-regulating factor discovered

German launch for ACE inhibitor

German introduction for hepatitis vaccine

Third launch for Zyprexa

Comparative study of second-generation t-PA inhibitor and alteplase

GDNF gene therapy for Parkinson's disease

Vaginal antifungal product cleared by FDA

Ampalex trial in AD begins

Magainin lead product licensed to SKB

Labeled SMART antibody shows promise for AML treatment

Encouraging results obtained for immunotoxin in Hodgkin's lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...